articleTop 1% cited

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers

Clinical Chemistry · 2008 · Vol. 54(12) · pp. e11–e79

Catharine M. Sturgeon✉(Edinburgh Royal Infirmary)Michael J. Duffy(St. Vincent's University Hospital)Ulf‐Håkan Stenman(Helsinki University Hospital)Hans Lilja(Memorial Sloan Kettering Cancer Center)Nils Brünner(University of Copenhagen)Daniel W. Chan(Johns Hopkins University)Richard J. Babaian(The University of Texas MD Anderson Cancer Center)Robert C. Bast(The University of Texas MD Anderson Cancer Center)Barry L. Dowell(Abbott Fund)Francisco J. Esteva(The University of Texas MD Anderson Cancer Center)Caj Haglund(Helsinki University Hospital)Nadia Harbeck(München Klinik)Daniel F. Hayes(University of Michigan–Ann Arbor)Mads Holten-Andersen(University of Copenhagen)George G. Klee(Mayo Clinic)R. Lamerz(LMU Klinikum)Leendert H. J. Looijenga(Erasmus MC Cancer Institute)Rafael Molina(Hospital Clínic de Barcelona)Hans Jørgen Nielsen(Hvidovre Hospital)Harry G. RittenhouseAxel SemjonowIe‐Ming Shih(Johns Hopkins University)Paul Sibley(Siemens (United Kingdom))György Sölétormos(University of Copenhagen)Carsten Stephan(Charité - Universitätsmedizin Berlin)Lori J. Sokoll(Johns Hopkins University)Barry Hoffman(Mount Sinai Hospital)Eleftherios P. Diamandis(University of Toronto)

View via DOI Publisher page

Abstract

Implementation of these recommendations should encourage optimal use of tumor markers.

Genetic factors in colorectal cancer Colorectal Cancer Treatments and Studies Colorectal Cancer Screening and DetectionMedicineProstateInternal medicineOncologyGynecologyClinical PracticeFamily medicineCancer

MeSH terms

Breast NeoplasmsFemaleHumansMaleOvarian NeoplasmsProstatic NeoplasmsReference ValuesTesticular NeoplasmsBiomarkers, TumorColorectal NeoplasmsClinical Laboratory Techniques